Ivacaftor approved for cystic fibrosis

被引：0
|
作者：
Traynor, Kate
机构：
来源：
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 2012年 / 69卷 / 05期
关键词：
D O I：
10.2146/news120015
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：363 / 363
页数：1
相关论文
共 50 条
  • [41] EFFECTS OF ELEXACAFTOR/ TEZACAFTOR/ IVACAFTOR ON MARKERS OF LIVER FIBROSIS IN ADULTS WITH CYSTIC FIBROSIS
    Portolese, Olivia
    Bilodeau, Marc
    Castel, Helene
    Willems, Bernard E.
    Huard, Genevieve
    Vincent, Catherine
    Lavoie, Annick
    Hercun, Julian
    [J]. HEPATOLOGY, 2023, 78 : S638 - S639
  • [42] Effects of elexacaftor/tezacaftor/ivacaftor on liver fibrosis markers in adults with cystic fibrosis
    Tewkesbury, Daniel H.
    Scott, Jennifer
    Barry, Peter J.
    Bright-Thomas, Rowland J.
    Hanley, Karen Piper
    Athwal, Varinder
    Jones, Andrew M.
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2024, 23 (02) : 349 - 353
  • [43] Cystic Fibrosis: recent Studies - new Drugs In June, new Data for Ivacaftor and Lumacaftor/Ivacaftor were presented at the Conference of the European Cystic Fibrosis Society
    不详
    [J]. PADIATRIE UND PADOLOGIE, 2016, 51 (04): : 186 - +
  • [44] PHARMACOKINETIC INTERACTION BETWEEN IVACAFTOR AND LUMACAFTOR IN CYSTIC FIBROSIS PATIENTS
    Hanafin, P.
    Rao, G.
    Schneider-Futschik, E.
    [J]. RESPIROLOGY, 2020, 25 : 58 - 58
  • [45] Aquagenic wrinkling of the palms in cystic fibrosis patients treated with ivacaftor
    Jacobi, Eyal
    Solomon, Melinda
    Avolio, Julie
    Shaw, Michelle
    Gonska, Tanja
    Ratjen, Felix
    Grasemann, Hartmut
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2022, 21 (02) : E102 - E105
  • [46] SAFETY AND EFFICACY OF LUMACAFTOR/IVACAFTOR IN PEDIATRIC CYSTIC FIBROSIS PATIENTS
    Wainwright, C.
    Chilvers, M.
    Hug, C.
    Marigowda, G.
    Tian, S.
    Solomon, M.
    Black, P.
    Rosenfeld, M.
    Sawicki, G.
    Hoppe, J.
    [J]. RESPIROLOGY, 2018, 23 : 141 - 141
  • [47] Impact of elexacaftor/tezacaftor/ivacaftor on depression and anxiety in cystic fibrosis
    Zhang, Lijia
    Albon, Dana
    Jones, Marieke
    Bruschwein, Heather
    [J]. THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2022, 16
  • [48] Ivacaftor-elexacaftor-tezacaftor and tacrolimus combination in cystic fibrosis
    Smith, Megan
    Ryan, Kevin J.
    Gutierrez, Hector
    Sanchez, Luz Helena Gutierrez
    Anderson, Janaina Nogueira
    Acosta, Edward P.
    Benner, Kim W.
    Guimbellot, Jennifer S.
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2022, 21 (01) : E8 - E10
  • [49] Ivacaftor/rifampicin interactionPulmonary exacerbation of cystic fibrosis: case report
    [J]. Reactions Weekly, 2018, 1693 (1) : 285 - 285
  • [50] Physiological Mechanisms Of Dyspnea Relief Following Ivacaftor In Cystic Fibrosis
    Schaeffer, M. R.
    Quon, B. S.
    Molgat-Seon, Y.
    Wilkie, S. S.
    Wilcox, P. G.
    Guenette, J. A.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
12345